| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.17 | 0.4 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.4 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |